13:33 26.04.26
Erstelle meine Watchlist und Depot login | Registrieren
Amgen Inc US0311621009

Amgen "neutral"

06.11.07 - UBS

NEW YORK, November 6 (newratings.com) - In a research note published yesterday, analyst Maged Shenouda of UBS maintains his "neutral" rating on Amgen Inc (AMGN). The 12 month target price is set to $61.

                                                                                                                        

Verbessern Sie newratings! Lob / Kritik?